The 2025 publication volume of the Archives of Advances in Biosciences reflects a field in rapid transition toward data-driven, interdisciplinary, and translational science. Key thematic areas include cancer research, with emphasis on peptide vaccines, biomarker discovery, computational drug screening, and photodynamic therapy; the pervasive integration of bioinformatics, molecular docking, and predictive modeling; ongoing investigations in immunology, infectious diseases, and long-term COVID-related health outcomes; and the continued relevance of natural product-derived compounds analyzed through modern analytical and computational platforms. Perhaps most notably, the year's contributions demonstrate the progressive erosion of traditional disciplinary boundaries, with successful bioscience research now requiring convergence across molecular biology, biotechnology, pharmacology, immunology, engineering, computational sciences, and clinical medicine. As artificial intelligence, multi-omics, precision diagnostics, and personalized therapeutics continue to mature, the editorial emphasizes that scientific rigor, reproducibility, and ethical responsibility must remain central to innovation. The collective work of authors, reviewers, and readers in 2025 underscores a shared commitment to translating fundamental discoveries into measurable improvements in human health.
Nayebali Ahmadi (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: